Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
2924433 | Heart Rhythm | 2006 | 6 Pages |
Abstract
Use of lipid-lowering drugs in patients with reduced LVEF is associated with a significant reduction in the prevalence of AF independent of the lipid profile and other known arrhythmia risk factors. This effect is larger than that of angiotensin-converting enzyme inhibitors/angiotensin receptor blockers or β-blockers and may be the result of the antioxidant and anti-inflammatory effects of statins and fibrates.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Ibrahim R. MD, Brent BS, Heather MS, Lynne MS, Diane BS, Samuel C. MD, PhD, John F. MD, Jonathan J. MD,